spacer
home > pmps > Winter 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
Optimising Profitability Potential remains a key aim for all companies, not just those in the pharmaceutical sector. Andre Grigjanis at IBS Pharma indicates the recompense that maximising supply chain efficiency, particularly in terms of inventory optimisation, can award  
view
download pdf
Carl Krüger at B2B Compliance summarises the Waste Electronic and Electrical Equipment legislation currently affecting all businesses and consumers, as well as the public sector. Pharma Asks: What can WEEE do?  
view
download pdf
The new FDA Directive – USP 797 – involves requirements contained in standard operating procedures that cannot be ignored. In Regulating Sterility, Harry Kirk of Nitritex takes us through the implications  
view
download pdf
bullet
Drug Delivery 
The circumstances in which a drug is used – for example in the home – can have a significant impact on its accurate and safe delivery. Shawn D Kinney, Andrea Wagner and Christian Phillips at HCM outline the advantages of bubble-free prefilled syringes in such a situation, in Bursting the Bubble  
view
download pdf
The Future is Disposable, and the benefits of user-friendly injection systems – fast developing into mainstream products – are multiple. Christian Husegaard at Bang & Olufsen Medicom argues the case for the predominance of disposable injectors in this growing field of drug delivery  
view
download pdf
The manufacture and development of specific APIs in a contract environment throws up a number of challenges, not to mention considerable cost and safety implications. William Bowtle at Encap Drug Delivery debates the issues, in Hazard Handling  
view
download pdf
In Vaginal Drug Delivery: The Progression of Novel Formulations, Janet Halliday at CT Scotland explores the development of new inhaled formulations and transdermal patches which continue to be of paramount importance to this specific market  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Monitoring and preventing the infiltration of impurities in pharmaceutical products – a high-impact problem both in terms of expense and safety – is an ongoing challenge for the industry. Dr Christian Zeine at LGC Standards GmbH investigates, in Pushing for Purity  
view
download pdf
Yann Bayeux at Pierre Fabre Medicament argues that scCO2 technology transcends traditional methods of enhancing bioavailability through Solving Solubility, and that supercritical fluid technology demands the same degree of research as solid forms of drug. He outlines the strategic advantages of such technology for businesses as a whole  
view
download pdf
bullet
IT and Logistics
Mike Hurst at Baxa Corporation urges us to Get Connected. The dangers and risks involved in the intravenous infusion of enteral feedings must continue to be fought across every institution, with help from novel solutions and technologies  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
The Demand for Digital is particularly high in the printing sector of the pharmaceutical industry. Christoph Staub at Hapa AG warns, however, that introducing compliance safeguards is imperative in order to gain optimum operational efficiency and customer satisfaction without increasing risk  
view
download pdf
Nicole Golomb at 3S Simons Security Systems endorses Total Transparency within the pharmaceutical industry, arguing that seamless tracking through out the supply chain is a necessity, and that a combination of barcodes and micro colour-code systems is the way to incorporate anti-counterfeiting across the board  
view
download pdf
Faced with mammoth counterfeiting challenges, validation through authentication at the point of dispensing has become a key tenet for the needs of the pharmaceutical sector, argues Brian Thornley at Aegate, in Verily Validated  
view
download pdf
Track-and-trace solutions work most effectively if tailored to individual supply chains, particularly in light of the number of times a product can change hands, argues Akan Oton at Catalent Pharma Solutions, in On the Right Track  
view
download pdf
Holographic Help is at hand; Ian Lancaster of the International Hologram Manufacturer’s Association (IHMA) describes how sophisticated holograms can combine authentication with detection in order to overcome the growing pharmaceutical counterfeit problem  
view
download pdf
Declan Bogan, along with Gary Leonard and Mike Bigwood at Steripack, assess the power and influence that product-need and cost considerations have over packaging manufacturing, in Packaging Properties  
view
download pdf
bullet
COOL CHAIN
The multiplicity of temperature loggers currently available on the market can be baffling, and the effect of different environmental conditions is often underestimated. Dave Ayres at Calibration Services guides us through the decision-making process, in Logger Logistics  
view
download pdf
Thinking Outside the Box is necessary in order to successfully maintain high standards throughout the supply chain for temperature-sensitive products. Handling procedures need to be pioneering and meticulously planned, expounds Johan Nordenberg at Envirotainer  
view
download pdf
   
spacer
Edited by
Robert Harris
Chief Technical Officer at Juniper Pharma Services
Published quarterly in
February, May,
August and November

News and Press Releases

Cancer immunotherapy with the help of CAR-T cells

Bielefeld, October 2017– PlasmidFactory, the leading contract manufacturer for plasmid and minicircle (MC) DNA, once again highlights the cooperation with the University Hospital of Würzburg and the MD-CEL – Helmholtz Innovation Lab at the Max Delbrück Centre (MDC) Berlin in the area of cancer immunotherapy. This cancer therapy uses CAR-T cells that recognise and destroy cancer cells. The patient’s own immune cells are removed, genetically modified, and then re-introduced into the body. In conventional immunotherapies, which have shown remarkable efficacy in clinical trials, T cells are modified by retroviral vectors. However, the potential for insertional mutagenesis and genotoxicity of viral vectors poses a safety risk, and the cost and regulatory requirements will stand in the way of a fast and broad clinical application. In late August, the first CAR-T cell therapy for acute lymphoblastic leukaemia (ALL) was approved in the US.
More info >>

White Papers

Clinical Research in Spain

BioClever

This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >>

Industry Events

Temperature Controlled Logistics 2018

29 January - 1 February 2018, Twickenham Stadium, London

Each January for the past 16 years, more than 400 senior supply chain, logistics, storage, regulation and quality experts from the pharmaceutical industry have gathered at the TCL Forum for the largest, longest running and most comprehensive cold chain and ambient logistics conference in Europe.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement